Company Profile
Oric Pharmaceuticals, Inc. Stock Price, News & Analysis
- Ticker:
- ORIC
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Oric Pharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
8.91 USD (-0.22%)
Close
Last updated: June 23, 2026 at 00:00
922.34M USD
Market cap
Why the stock is moving
ORIC is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Oric Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Oric Pharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Oric Pharmaceuticals follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Oric Pharmaceuticals sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
Source: Oric Pharmaceuticals, Inc.
- 02
ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Updates
Source: Oric Pharmaceuticals, Inc.
- 03
- 04
ORIC® Pharmaceuticals to Report Combination Dose Optimization Data From Phase 1b Trial of Rinzimetostat in Patients with mCRPC
Source: Oric Pharmaceuticals, Inc.
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Oric Pharmaceuticals, Inc. (ORIC)?
Oric Pharmaceuticals, Inc. (ORIC) most recently closed at 8.91 USD, a -0.22% move versus the previous session.
What is the market cap of Oric Pharmaceuticals, Inc. (ORIC)?
Oric Pharmaceuticals, Inc. currently has a market capitalization of 922.34M USD on BioPharmSignal.
What does Oric Pharmaceuticals, Inc. do?
Oric Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is ORIC stock listed?
Oric Pharmaceuticals, Inc. (ORIC) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Oric Pharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Oric?
Oric Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Oric Pharmaceuticals, Inc. targeting with Oric?
Oric Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Pharmaceuticals?
Oric Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.